Rapport Therapeutics (RAPP) Other Non-Current Assets (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 400.95% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 400.95% increase from a year earlier, with the FY2025 full-year figure at $985000.0, up 515.62% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.1 million, up from $985000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for RAPP reached as high as $1.1 million in Q3 2025 and fell as low as $160000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $604888.9 across 4 years, with a median of $551000.0 in 2023.
• Across the five-year window, Other Non-Current Assets slumped 70.96% in 2024 and surged 515.62% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $551000.0 in 2023, then slumped by 70.96% to $160000.0 in 2024, then jumped by 515.62% to $985000.0 in 2025, then grew by 7.31% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.1 million in Q1 2026, $985000.0 in Q4 2025, and $1.1 million in Q3 2025.